Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/05/025028
CTRI/2020/05/025028
Not Yet Recruiting
Phase 3

Comparison of changes in the bone thickness,transverse arch dimensions and arch length between conventional brackets and the Passive self ligating brackets with different arch wire combinations using CBCT and Digital models - DAPS

Ormco Asia0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ormco Asia
Status
Not Yet Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ormco Asia

Eligibility Criteria

Inclusion Criteria

  • •1\.Non Extraction Orthodontic treatment with a space discrepancy more than 5mm.
  • •2\. Permanent dentition with full compliment of teeth excluding third molars.
  • •3\. No relevant medical history.Â

Exclusion Criteria

  • •1\. Mixed dentition.
  • •2\. Previous history of orthodontic treatment.
  • •3\. Tooth with developmental anomalies and fluorosis.
  • •4\. Restoration involving labial surface of tooth.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
To compare the gain in bone dimension of extraction socket after bone graft placement and without itHealth Condition 1: K053- Chronic periodontitis
CTRI/2023/08/056065Mansi Sharma32
Not Yet Recruiting
Phase 2
Effect of 1% Metformin gel on bone density.
CTRI/2024/05/067922Dr Tushar Mohata
Not Yet Recruiting
N/A
Comparing bone strength and implant stability in people with high cholesterol levelsHealth Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
CTRI/2024/07/070551Datta Meghe Institute of Higher Education and Research
Active, Not Recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
N/A
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibody
ISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46